Progression of Chronic Kidney Disease and All-Cause Mortality in Patients with Tricuspid Regurgitation

被引:0
|
作者
Schipmann, Fabian [1 ,2 ]
Bannehr, Marwin [1 ,2 ]
Haehnel, Valentin [1 ,2 ]
Dworok, Victoria [1 ,2 ]
Nuebel, Jonathan [1 ,2 ]
Edlinger, Christoph [1 ,2 ,3 ]
Lichtenauer, Michael [3 ]
Haase, Michael [4 ]
Zaenker, Michael [5 ]
Butter, Christian [1 ,2 ]
Haase-Fielitz, Anja [1 ,2 ,6 ]
机构
[1] Brandenburg Med Sch MHB Theodor Fontane, Dept Cardiol, Heart Ctr Brandenburg Bernau, Ladeburger Str 17, D-16321 Bernau, Germany
[2] Brandenburg Med Sch MHB Theodor Fontane, Fac Hlth Sci FGW Brandenburg, Ladeburger Str 17, D-16321 Bernau, Germany
[3] Paracelsus Med Univ Salzburg, Dept Cardiol, Clin Internal Med 2, A-5020 Salzburg, Austria
[4] Otto von Guericke Univ, Med Fac, D-39120 Magdeburg, Germany
[5] Heart Ctr Brandenburg Bernau, Brandenburg Med Sch MHB Theodor Fontane, Dept Internal Med, D-16321 Bernau, Germany
[6] Otto von Guericke Univ, Inst Social Med & Hlth Syst Res, D-39120 Magdeburg, Germany
关键词
tricuspid regurgitation; long-term mortality; chronic kidney disease; CKD progression; cardio-renal; PULMONARY-HYPERTENSION; CARDIOVASCULAR RISK; RENAL-FUNCTION; VALVE REPAIR; OUTCOMES; PREVALENCE; EPIDEMIOLOGY; ASSOCIATION;
D O I
10.3390/diseases10010016
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: The impact of chronic kidney disease (CKD) on patient-related outcomes in patients with tricuspid regurgitation (TR) is well known. However, the impact of the progression of CKD in patients with TR and potentially modifiable risk factors of progressing CKD is unknown. Methods: 444 consecutive adult patients with TR and CKD stage 1-4 admitted in an inpatient setting between January 2010 and December 2017 were included. During a median follow-up of two years, eGFR and survival status were collected. Independent risk factors for CKD progression and all-cause mortality were determined. Patient survival statuses were grouped according to different combinations of the presence or absence of CKD progression and the TR grade. Results: Progression of CKD (OR 2.38 (95% confidence interval 1.30-4.35), p = 0.005), the grade of TR (OR 2.38 (1.41-4.00), p = 0.001) and mitral regurgitation (OR 1.72 (1.20-2.46), p = 0.003) were independent risk factors for all-cause mortality. Haemoglobin at admission (OR 0.80 (0.65-0.99), p = 0.043) and the presence of type 2 diabetes (OR 1.67 (1.02-2.73), p = 0.042) were independent risk factors for CKD progression. The combination of the status of CKD progression and the TR grade showed a stepwise pattern for all-cause mortality (p < 0.001). Patients with CKD progression and TR grade 1 had comparable all-cause mortality with patients without CKD progression but with TR grade 2 or 3. Even in patients with TR grade 1, the risk for all-cause mortality doubled if CKD progression occurred (OR 2.49 (95% CI 1.38-4.47), p = 0.002). Conclusion: CKD progression appears to be a risk factor for all-cause mortality in patients with TR. Anaemia and diabetes are potential modifiers of CKD progression.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Abnormal Serum Potassium is Associated With Risk of Chronic Kidney Disease Progression and All-Cause Mortality in Patients With Chronic Kidney Disease
    O'Connell, Samantha
    Stefanescu, Andrei R.
    Cueto, Jenilee
    He, Hua
    Chen, Jing
    Grams, Morgan
    Anderson, Amanda H.
    He, Jiang
    Mills, Katherine T.
    CIRCULATION, 2023, 147
  • [2] PROGRESSION OF CHRONIC KIDNEY DISEASE AND LONG-TERM MORTALITY IN PATIENTS HOSPITALIZED WITH TRICUSPID REGURGITATION
    Elitok, Saban
    Haase-Fielitz, Anja
    Ernst, Martin
    Haase, Michael
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [3] Circulating Osteoprotegerin in Chronic Kidney Disease and All-Cause Mortality
    Kaminska, Joanna
    Stopinski, Marek
    Mucha, Krzysztof
    Pac, Michal
    Golebiowski, Marek
    Niewczas, Monika A.
    Paczek, Leszek
    Foroncewicz, Bartosz
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 2413 - 2420
  • [4] Nonlinearity association between hyperuricemia and all-cause mortality in patients with chronic kidney disease
    Liu, Ya-Fei
    Han, Liang
    Geng, Yin-Hong
    Wang, Huan-Huan
    Yan, Jia-Hui
    Tu, Sheng-Hao
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [5] Smoking increases the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease
    Nakamura, Koshi
    Nakagawa, Hideaki
    Murakami, Yoshitaka
    Kitamura, Akihiko
    Kiyama, Masahiko
    Sakata, Kiyomi
    Tsuji, Ichiro
    Miura, Katsuyuki
    Ueshima, Hirotsugu
    Okamura, Tomonori
    KIDNEY INTERNATIONAL, 2015, 88 (05) : 1144 - 1152
  • [6] Nonlinearity association between hyperuricemia and all-cause mortality in patients with chronic kidney disease
    Ya-Fei Liu
    Liang Han
    Yin-Hong Geng
    Huan-Huan Wang
    Jia-Hui Yan
    Sheng-Hao Tu
    Scientific Reports, 14
  • [7] The effect of sleep apnea on all-cause mortality in nondialyzed chronic kidney disease patients
    Xu, Jianwei
    Yoon, In Young
    Chin, Ho Jun
    SLEEP MEDICINE, 2016, 27-28 : 32 - 38
  • [8] METABOLIC ACIDOSIS IS A PREDICTIVE FACTOR FOR ALL-CAUSE MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Tangri, Navdeep
    Reaven, Nancy
    Funk, Susan E.
    Mathur, Vandana
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 642 - 642
  • [9] Association of TSH Elevation with All-Cause Mortality in Elderly Patients with Chronic Kidney Disease
    Chuang, Mei-hsing
    Liao, Kuo-Meng
    Hung, Yao-Min
    Chou, Yi-Chang
    Chou, Pesus
    PLOS ONE, 2017, 12 (01):
  • [10] Serum metabolites are associated with all-cause mortality in chronic kidney disease
    Hu, Jiun-Ruey
    Coresh, Josef
    Inker, Lesley A.
    Levey, Andrew S.
    Zheng, Zihe
    Rebholz, Casey M.
    Tin, Adrienne
    Appel, Lawrence J.
    Chen, Jingsha
    Sarnak, Mark J.
    Grams, Morgan E.
    KIDNEY INTERNATIONAL, 2018, 94 (02) : 381 - 389